CÁC YẾU TỐ LIÊN QUAN ĐẾN THẤT BẠI ĐIỀU TRỊ BẰNG THUỐC KHÁNG VIRUS Ở TRẺ NHIỄM HIV/ AIDS TẠI BỆNH VIỆN A THÁI NGUYÊN
Thông tin bài báo
Ngày nhận bài: 29/08/24                Ngày hoàn thiện: 17/12/24                Ngày đăng: 18/12/24Tóm tắt
Từ khóa
Toàn văn:
PDFTài liệu tham khảo
[1] Vietnam Ministry of Health, Treatment and basic care for children infected with HIV/AIDS, Report No. 4746/QD-BYT dated December 08, 2010, 2011.
[2] World Health Organization, Latest HIV estimates and updates on HIV policies uptake, December 2021.
[3] The Joint United Nations s Programme on HIV/AIDS. UNAIDS DATA 2023. (UNAIDS, 2023).
[4] X. Zeng et al., “Treatment Outcomes of HIV Infected Children After Initiation of Antiretroviral Therapy in Southwest China: An Observational Cohort Study,” Front Pediatr., vol. 10, 2022, Art. no. 916740, doi: 10.3389/fped.2022.916740.
[5] S. Sivapalasingam et al., “The importance of caregivers in the outcome of pediatric HIV management, Mombasa, Kenya,” AIDS Care, vol. 26, pp. 425-433, 2014, doi: 10.1080/09540121.2013.841829.
[6] P. De Beaudrap, et al., “CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Cote d'Ivoire,” J Acquir Immune Defic Syndr., vol. 49, pp. 70-76, 2008, doi:10.1097/QAI.0b013e3181831847.
[7] S. A. Weldemariam, Z. Dagnew, Y. Tafere, T. M. Bereka, and Y. B. Bitewa, “Time to death among HIV-infected under-five children after initiation of anti-retroviral therapy and its predictors in Oromiya liyu zone, Amhara region, Ethiopia: a retrospective cohort study,” BMC Pediatr., vol. 22, no. 5, 2022, doi:10.1186/s12887-021-03072-6.
[8] P. Frange, et al., “Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents - The-ANRS-EP59-CLEAC Study,” Front Immunol., vol. 12, 2021, Art. no. 662894, doi:10.3389/fimmu.2021.662894.
[9] Vietnam Ministry of Health, Guidelines for HIV/AIDS Treatment and Care, Report No. 5968/QD-BYT dated December 31, 2021, 2021.
[10] S. P. Koenig et al., "Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial," PLoS Med, vol. 14, no. 7, Jul 2017, Art. no. e1002357.
[11] S. T. Mengistu et al., “Prevalence and factors associated with pediatric HIV therapy failure in a tertiary hospital in Asmara, Eritrea: A 15-year retrospective cohort study,” PLoS One, vol. 18, 2023, Art. no. e0282642, doi: 10.1371/journal.pone.0282642.
[12] E. B. Wondifraw, N. B. Tebeje, W. Akanaw, and E. S. Chanie, "Predictors of first-line antiretroviral treatment failure among children on antiretroviral therapy at the University of Gondar comprehensive specialised hospital, North-west, Ethiopia: a 14-year long-term follow-up study," BMJ Open, vol. 12, no. 12, 2022, Art. no. e064354.
[13] S. Yassin and G. B. Gebretekle, “Magnitude and predictors of antiretroviral treatment failure among HIV-infected children in Fiche and Kuyu hospitals, Oromia region, Ethiopia: A retrospective cohort study,” Pharmacol Res Perspect, vol. 5, 2017, Art. no. e00296, doi: 10.1002/prp2.296.
[14] M. Sibhat, M. Kassa, and H. Gebrehiwot, "Incidence and Predictors of Treatment Failure Among Children Receiving First-Line Antiretroviral Treatment in General Hospitals of Two Zones, Tigray, Ethiopia, 2019," Pediatric Health Med Ther, vol. 11, pp. 85-94, 2020.
[15] G. S. Haile and A. B. Berha, "Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia," BMC Pediatr, vol. 19, no. 1, p. 37, Jan 29, 2019.
[16] Getaneh et al., "Rate and predictors of Treatment Failure among pediatric population taking Highly Active Antiretroviral Therapy in Ethiopia," Journal of AIDS and HIV Treatment, vol.1, no. 1, pp. 58-68, 2019.
DOI: https://doi.org/10.34238/tnu-jst.11030
Các bài báo tham chiếu
- Hiện tại không có bài báo tham chiếu